Laboratorios Farmaceuticos Rovi(DE:41L)
€69.85-0.10 (-0.14%)
DE:41L
Laboratorios Farmaceuticos Rovi earnings date
€69.85
At close:-0.10 (-0.14%)
Laboratorios Farmaceuticos Rovi (41L) Q2 2021 Earnings Report
4 Followers
DE:41L Q2 2021 EPS Results
- Actual EPS
- EUR 0.49
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- EUR 0.28
DE:41L Q2 2021 Revenue Results
- Actual Revenue
- EUR 159.50M
- Expected Revenue
- EUR 127.54M
- Beat/Miss
- Beat by +EUR 31.96M
- YoY Revenue Growth
- +76.90%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 07/28/2021
- Time
- TBA
- Conference Call
- Wednesday, July 28, 2021
DE:41L Upcoming Earnings
Laboratorios Farmaceuticos Rovi's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:41L Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | ―- | 0.83 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | ―1.53 | 1.13 | 35.19% (+0.40) | |
| Jul 23, 2026 | 2026 (Q2) | ―1.47 | 0.42 | 246.57% (+1.04) | |
| May 06, 2026 | 2026 (Q1) | ―0.18 | 0.35 | -47.74% (-0.17) | |
| Feb 25, 2026 | 2025 (Q4) | ―0.83 | 0.46 | 82.49% (+0.38) | |
| Nov 06, 2025 | 2025 (Q3) | ―1.13 | 0.86 | 31.86% (+0.27) | |
| Jul 24, 2025 | 2025 (Q2) | ―0.42 | 0.86 | -50.81% (-0.44) | |
| May 08, 2025 | 2025 (Q1) | ―0.35 | 0.29 | 22.49% (+0.07) | |
| Feb 25, 2025 | 2024 (Q4) | ―0.46 | 0.99 | -54.02% (-0.54) | |
| Nov 07, 2024 | 2024 (Q3) | ―1.36 | 0.98 | 39.47% (+0.39) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

